Product and Service [Axis]
Product Sales Net [Member]
Other Revenues [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Investment, Name [Axis]
Surface Ophthalmics, Inc. [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Antidilutive Securities [Axis]
Stock Options, Unvested RSUs And Unvested PSUs [Member]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
Legal Entity [Axis]
Investment, Issuer Name [Axis]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Debt Instrument [Axis]
2030 Notes [Member]
2026 Notes [Member]
2027 Notes [Member]
Fair Value, Inputs, Level 2 [Member]
Oaktree Loan [Member]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
Chargebacks [Member]
Government Rebates [Member]
Allowances For Sales Returns [Member]
Administrative Fees and Other Rebates [Member]
Co Pay Assistance [Member]
Reserves For Cash Discount [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Asset Purchase, License and Related Agreements [Member]
Samsung Agreement [Member]
Formosa Agreement [Member]
Business Combination [Axis]
VEVYE [Member]
Santen Products Acquisition [Member]
Asset Acquisition [Axis]
Scenario [Axis]
One Time Payment [Member]
Asset Purchase Agreement [Member]
Novartis [Member]
Melt Loan Agreement [Member]
Class of Stock [Axis]
Series B1 Preferred Stock [Member]
Series B Preferred Stock [Member]
Merger Agreement [Member]
Related Party Transaction [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Capitalized Software Development Costs [Member]
Third Party Software License [Member]
Patents [Member]
Licenses [Member]
Indefinite-Lived Intangible Assets [Axis]
Trademarks [Member]
Acquired Product Rights [Member]
Customer Relationships [Member]
Trade Names [Member]
State Pharmacy Licenses [Member]
Non-Competition Clause [Member]
Fifth Third Revolving Credit Facility [Member]
Credit Facility [Axis]
Senior Secured Revolving Credit Facility [Member]
Revolving Credit Facility [Member]
Secured Overnight Financing Rate (SOFR) [Member]
Long-Term Debt, Type [Axis]
Senior Notes Due 2030 [Member]
Other Offering Expense [Member]
Second Amendment [Member]
Oaktree Fund Administration LLC [Member]
Oaktree Loan Due 2026 [Member]
8.625% Senior Notes Due 2026 [Member]
Title and Position [Axis]
Investor [Member]
11.875% Senior Notes Due 2027 [Member]
Loan and Security Agreement [Member]
BR Loan [Member]
8.625% Senior Notes due September 2030 [Member]
Oaktree Loan due January 2026 [Member]
Long-Lived Tangible Asset [Axis]
Office and Laboratory Space [Member]
Geographical [Axis]
Carlsbad [Member]
Ledgewood [Member]
Lease Amendment [Member]
Nashville [Member]
Statement of Income Location, Balance [Axis]
Selling, General and Administrative Expenses [Member]
Plan Name [Axis]
2017 Incentive Stock and Awards Plan [Member]
Two Thousand And Fifty Five Incentive Stockand Awards Plan [Member]
Share-Based Payment Arrangement, Option [Member]
Employees and Consultant [Member]
Employees and Directors [Member]
Performance Stock Units PSU [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
Share Based Compensation Award Tranche Four [Member]
Phantom Share Units (PSUs) [Member]
Performance Stock Units [Member]
Directors [Member]
Employees [Member]
Stock Option Plan [Member]
Exercise Price Range [Axis]
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Range Seven [Member]
Range Eight [Member]
Range Nine [Member]
Range Ten [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Payment Arrangement, Tranche Three [Member]
Performance Shares [Member]
Research and Development Expense [Member]
Director [Member]
Consultants [Member]
Tax Period [Axis]
Tax Year 2032 [Member]
Income Tax Jurisdiction [Axis]
State and Local Jurisdiction [Member]
TENNESSEE
COLORADO
NEW JERSEY
MASSACHUSETTS
Other [Member]
Loss Contingency Nature [Axis]
Punitive Damages [Member]
Actual Damages [Member]
Litigation Case [Axis]
OSRX Liability [Member]
Forecast [Member]
Customer [Axis]
Two Customer [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
No Customer [Member]
Three Customers [Member]
Accounts Receivable [Member]
Two Suppliers [Member]
Purchases [Member]
Supplier Concentration Risk [Member]
Segments [Axis]
Branded [Member]
Consolidation Items [Axis]
Operating Segments [Member]
ImprimisRx [Member]
Other Commitments [Axis]
Selling General And Administrative Expense [Member]
Research And Development Expenses [Member]
IHEEZO [Member]
Product Concentration Risk [Member]
Revenue, Product and Service Benchmark [Member]
Other Products [Member]
Other Revenue [Member]
Reportable Segment, Aggregation before Other Operating Segment [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Santen Agreements [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Name
Auditor Location
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Capitalized software costs, net
Operating lease right-of-use assets, net
Intangible assets, net
Goodwill
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses
Accrued rebates and copay assistance
Accrued payroll and related liabilities
Deferred revenue and customer deposits
Current portion of operating lease obligations
Total current liabilities
Operating lease obligations, net of current portion
Notes payable, net of unamortized debt discount
TOTAL LIABILITIES
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 50,000,000 shares authorized; 37,229,159 and 35,622,214 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively
Additional paid-in capital
Accumulated deficit
TOTAL HARROW, INC. STOCKHOLDERS’ EQUITY
Noncontrolling interests
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Statement [Table]
Statement [Line Items]
Revenues:
Total revenues
Cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Impairment of long-lived assets
Total operating expenses
Income from operations
Other (expense) income:
Interest expense, net
Investment (loss) gain from Eton Pharmaceuticals
Loss on extinguishment of debt
Other income (expense), net
Total other expense, net
Loss before income taxes
Income tax expense
Net loss
Basic net loss per share of common stock
Diluted net loss per share of common stock
Weighted average number of shares of common stock outstanding, basic
Weighted average number of shares of common stock outstanding, diluted
Balance
Balance, shares
Public offering, net of offering costs
Public offering, net of offering costs, shares
Exercise of consultant stock-based options
Exercise of consultant stock-based options, shares
Exercise of employee stock-based options
Exercise of employee stock-based options, shares
Vesting of PSUs and RSUs
Vesting of PSUs and RSUs, shares
Shares withheld related to net share settlement of equity awards
Shares withheld related to net share settlement of equity awards, shares
Stock-based compensation expense
Net loss
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of property, plant and equipment and software development costs
Amortization of intangible assets
Non-cash lease expense
Acquisition of Melt Pharmaceuticals
Provision for credit losses
Amortization of debt issuance costs and debt discount
Investment loss (gain) from investment in Eton
Loss on disposal of equipment
Impairment of intangible assets
Loss on extinguishment of debt
Stock-based compensation
Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Accounts payable, accrued expenses, accrued rebates and copay assistance
Accrued payroll and related liabilities
Deferred revenue and customer deposits
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES
Net proceeds on sale of investment in Eton Pharmaceuticals
Acquisition of Melt Pharmaceuticals
Investment in patent and trademark assets
Purchase of product rights and related patents
Purchases of property, plant and equipment
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from 11.875% notes payable, net of costs
Net proceeds from public offering
Proceeds from new debt, net of costs
Repayment of notes payable, inclusive of costs
Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options
Proceeds from exercise of stock options
Payment of debt issuance costs
Proceeds from public offering of common stock, net of offering costs
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of period
CASH AND CASH EQUIVALENTS, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrual of milestone payment
Reclassification of deferred financing costs
Accrual of exit fee related to Oaktree Loan
Purchase of property, plant and equipment included in accounts payable and accrued expenses
Change in right-of-use assets for operating lease obligations assumptions
Right-of-use assets obtained in exchange for new operating lease obligations
Reclass of deferred commitment fees from prepaid expenses into debt issuance costs
Insurance premium financed
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Revenue from Contract with Customer [Abstract]
REVENUES
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
RECENT PRODUCT ACQUISITIONS AND LICENSES
Investments, Debt and Equity Securities [Abstract]
INVESTMENT IN MELT PHARMACEUTICALS, INC. AND AGREEMENTS – RELATED PARTY TRANSACTIONS
Investment In Surface Ophthalmics Inc. And Agreements - Related Party Transactions
INVESTMENT IN SURFACE OPHTHALMICS, INC. AND AGREEMENTS - RELATED PARTY TRANSACTIONS
Inventory Disclosure [Abstract]
INVENTORIES
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT
Capitalized Software Costs
CAPITALIZED SOFTWARE COSTS
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND GOODWILL
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Debt Disclosure [Abstract]
DEBT
Leases
LEASES
Equity [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION
Income Tax Disclosure [Abstract]
INCOME TAXES
Retirement Benefits [Abstract]
EMPLOYEE SAVINGS PLAN
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Segment Reporting [Abstract]
SEGMENTS AND CONCENTRATIONS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Use of Estimates
Risks and Uncertainties
Credit Losses
Business Combinations and Asset Acquisitions
Noncontrolling Interests
Revenue Recognition and Deferred Revenue
Cost of Sales
Research and Development
Advertising Expense
Debt Issuance Costs and Debt Discount
Intellectual Property
Income Taxes
Cash and Cash Equivalents
Concentrations of Credit Risk
Accounts Receivable
Inventories
Investment in Surface Ophthalmics, Inc. – Related Party
Property, Plant and Equipment
Capitalized Software Costs
Intangible Assets, including Goodwill
Impairment of Other Long-Lived Assets
Leases
Fair Value Measurements
Stock-Based Compensation
Basic and Diluted Net Loss per Common Share
Reclassifications
Recently Adopted Accounting Pronouncements
Accounting Guidance Issued but Not Adopted at December 31, 2025
SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE OF CREDIT LOSS
SCHEDULE OF INVESTMENT
SCHEDULE OF ESTIMATED FAIR VALUE
SCHEDULE OF ACCRUALS AND ALLOWANCES
SCHEDULE OF INVENTORIES
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT
SCHEDULE OF CAPITALIZED SOFTWARE COSTS
SCHEDULE OF INTANGIBLE ASSETS
SCHEDULE OF AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES
SCHEDULE OF LONG TERM DEBT
SCHEDULE OF FUTURE MINIMUM PAYMENT UNDER NOTES PAYABLES
SCHEDULE OF FUTURE LEASE PAYMENTS UNDER OPERATING LEASES
SCHEDULE OF STOCK OPTION PLAN ACTIVITY
SCHEDULE OF FAIR VALUE ASSUMPTIONS
SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE
SCHEDULE OF PERFORMANCE STOCK UNITS
SCHEDULE OF PERFORMANCE STOCK UNITS ACTIVITY
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY
SCHEDULE OF STOCK BASED COMPENSATION GRANTED TO EMPLOYEES, DIRECTORS AND CONSULTANTS
SCHEDULE OF PROVISION FOR INCOME TAXES
SCHEDULE OF INCOME TAX RATE AND TAX PROVISION
SCHEDULE OF INCOME TAX RATE
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES
SCHEDULE OF VALUATION ALLOWANCE
SCHEDULE OF STATE INCOME TAX PAID
SCHEDULE OF UNRECOGNIZED TAX BENEFITS
SCHEDULE OF SEGMENT NET REVENUES
SCHEDULE OF REVENUES BY SEGMENT
AccountingPoliciesTable [Table]
AccountingPoliciesLineItems [Line Items]
Consolidation basis description
Accounts receivable, net of allowances for credit losses
Noncontrolling interest, description
Advertising expense
Unrecognized tax benefits
Accrual for interest and penalties
Recognized interest and penalties
Cash, FDIC Insured Amount
Accounts receivable, contractual adjustments
Accounts receivable, after allowance for credit loss and contractual adjustments
Investment owned balance shares
Ownership percentage
Share of Equity Method Losses
Property, plant and equipment, useful life
Finite lived intangible asset useful life
Impairment of indefinite-lived intangible assets
Stock options, unvested RSUs, and unvested PSUs
Vested but unissued RSUs
Beginning balance
Change in expected credit losses
Write-offs, net of recoveries
Ending balance
Schedule of Investments [Table]
Schedule of Investments [Line Items]
Cost Basis
Share of Equity Method Losses
Net carrying value
Platform Operator, Crypto Asset [Table]
Platform Operator, Crypto Asset [Line Items]
Carrying value
Fair value
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Balance
Accruals/Adjustments
Credits Taken Against Reserve
Balance
Business Combination [Table]
Business Combination [Line Items]
Royalty expense
Upfront and milestone payments
Payment for acquisition of intangible assets
Description of licenses agreements
Business acquired percentage
Costs incurred
Term milestone payment
Purchase price asset acquisition
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Note receivable
Shares issued upon investment under equity method
Investment accounted under equity method
Outstanding note receivable
Purchase of in-process research and development
Contingent obligation
Contingent obligation related to purchase of intangibles shares
Description for annual net sales milestones
Asset acquisition consideration
Other costs
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Investment owned shares
Raw materials
Work in progress
Finished goods
Total inventories
Prepaid insurance
Prepaid computer software related expenses
Prefunded Co-Pay assistance
Other prepaid expenses
Receivable due from Melt
Annual user fees (PDUFA)
Deposits and other current assets
Total prepaid expenses and other current assets
Computer hardware
Furniture and equipment
Lab and pharmacy equipment
Leasehold improvements
Property, plant and equipment, gross
Accumulated depreciation
Total property, plant and equipment, net
Depreciation and amortization expenses
Intangible Asset, Finite-Lived [Table]
Finite-Lived Intangible Assets [Line Items]
Total gross capitalized software for internal use
Accumulated amortization
Total capitalized software costs net
Amortization expenses
Useful life
Cost
Accumulated amortization
Impairment
Net Carrying value
Useful life, description
Cost
Accumulated amortization
Impairment
Amortization expense of intangible assets
2026
2027
2028
2029
2030
Thereafter
Intangible assets
Impairment charge
Payment to acquire intangible assets
Carrying value of goodwill
Accounts payable
Accrued interest
Other
Total accounts payable and accrued expenses
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Notes payable gross
Less: Unamortized debt issuance costs
Notes payable net
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Debt instrument interest rate, during period
Maturity period
2026
2027
2028
2029
2030
Thereafter
Total minimum payments
Less: unamortized discount, net of premium
Notes payable, net of unamortized discount
Initial principal amount
Debt instrument maturity date
Debt instrument basis spread on variable rate
Unused fee rate
Underwriting discounts to insurance
Debt principal amount
Interest rate
Net proceeds from issuance of notes
Redemption price percentage
Interest expense
Commitment fee percentage for undrawn amount
Fee
Repayments of debt
Unaccrued exit fee
Make whole premium amount
Write off of unamortized debt issuance costs
Loss on debt extinguishment
Amortization of deferred commitment fees
Debt instrument increase (decrease) for period net
Interest expense
Unaccrued interest
Unamortized debt issuance costs
Shares issued price per share
Effective interest rate
LeasesTable [Table]
Lessee, operating lease, remaining lease term
Area of land
Lease expiration date, description
Area of land
Weighted average incremental borrowing rate
Weighted average remaining lease term
Operating lease payments
Operating lease expense
Schedule Of Future Lease Payments Under Operating Leases
2026
2027
2028
2029
2030
Thereafter
Total minimum lease payments
Less: amount representing interest payments
Total operating lease liabilities
Less: current portion, operating lease liabilities
Operating lease liabilities, net of current portion
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, outstanding, beginning balance
Weighted average exercise price, outstanding, beginning balance
Number of shares, options granted
Weighted average exercise price, options granted
Number of shares, options exercised
Weighted average exercise price, options exercised
Number of shares, options cancelled/forfeited
Weighted average exercise price, options cancelled/forfeited
Number of shares, outstanding, ending balance
Weighted average exercise price, outstanding, ending balance
Weighted average. remaining contractual life, options outstanding
Aggregate intrinsic value, options outstanding
Number of shares, options exercisable
Weighted average exercise price, options exercisable
Weighted average. remaining contractual life, options exercisable
Aggregate intrinsic value, options exercisable
Number of shares, options vested and expected to vest
Weighted average exercise price, options vested and expected to vest
Weighted average. remaining contractual life, options vested and expected to vest
Aggregate intrinsic value, options exercisable
Weighted-average fair value of options granted
Expected terms (in years)
Expected volatility minimum
Expected volatility maximum
Risk-free interest rate minimum
Risk-free interest rate maximum
Dividend yield
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, minimum
Range of Exercise Prices, maximum
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding
Weighted Average Remaining Contractual Life in Years
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Weighted Average Exercisable Exercise Price
Target Share Price
Number of Shares
Number of Shares, unvested, outstanding, beginning balance
Weighted average grant date fair value, beginning balance
Number of Shares, PSUs granted
Weighted average grant date fair value, PSUs granted
Number of Shares, PSUs vested
Weighted average grant date fair value, PSUs vested
Number of Shares, PSUs cancelled/forfeited
Weighted average grant date fair value, PSUs cancelled/forfeited
Number of Shares, unvested, outstanding, ending balance
Weighted average grant date fair value, ending balance
Number of Shares, RSUs granted
Weighted average grant date fair value, RSUs granted
Number of Shares, RSUs vested
Weighted average grant date fair value, RSUs vested
Number of Shares, RSUs cancelled/forfeited
Weighted average grant date fair value, RSUs cancelled/forfeited
ScheduleOfStockBasedCompensationGrantedToEmployeesDirectorsAndConsultantsTable [Table]
Total
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized
Preferred stock, par or stated value per share
Preferred stock, shares issued
Preferred stock, shares outstanding
Share-based compensation awards, shares
Share price per share
Number of shares sold
Proceeds from issuance of common stock
Other offering expenses
Shares issued for common stock
Shares available for future issuances
Closing price of common stock price per share
Intrinsic value of options exercised
Recognized tax benefit from stock options exercised
Vesting term description
Forfeiture factor rate
Unrecognized compensation expense
Weighted-average period years
Stock-based compensation
Number of shares granted
Share price
Number of restrcited shares, value
Fair value expected term
Volatility rate
Risk-free interest rate
Fair value amortization term
Stock issued during the period, shares
Recognized tax benefit from the vesting
Number of restrcited shares, description
Tax benefit from stock options exercised
Current:
Federal
State
Foreign
Total current
Deferred:
Federal
Foreign
State
Total deferred
Income tax provision
U.S. federal statutory tax rate, amount
U.S. federal statutory tax rate, percentage
State and Local Income Taxes, Net of Federal Income Tax Effect, amount
State and Local Income Taxes, Net of Federal Income Tax Effect, percentage
Research and development tax credit, amount
Research and development tax credits, percentage
Change in valuation allowance, amount
Change in valuation allowance, percentage
Executive compensation limitations, amount
Executive compensation limitations, percentage
Stock compensation windfalls, amount
Stock compensation windfalls, percentage
Transaction fees, amount
Transaction fees, percentage
Incentive stock option, amount
Incentive stock option, percentage
Meals and Entertainment, amount
Meals and Entertainment, percentage
Other Permanent Adjustments, amount
Other permanent adjustments, percentage
Changes unrecognized tax benefits, amount
Changes unrecognized tax benefits, percentage
Return to Provision, amount
Return to provision, percentage
Effective income tax rate
Effective income tax rate, percentage
U.S. federal statutory tax rate
State tax benefit, net
Rate change
Employee stock-based compensation
Excess Employee remuneration
Melt loan settlement
Other
Uncertain tax positions
Research and development tax credit
Provision-to-return true-ups
Other true-ups
Total
Change in valuation allowance
Effective income tax rate
Net operating loss carryforwards
Interest expense limitation carryforwards
Capitalized research & experimentation
Amortization
Accrued chargebacks & returns
Stock compensation
Investment in Melt Pharmaceuticals
Accrued rebates
Lease liability
Accrued bonus
Obsolete inventory reserve
Accrued vacation
Research credit carryforwards
Other accruals and reserves
Total deferred tax assets
Valuation allowances
Net deferred tax assets
Prepaid expenses
Tax accounting method change
Depreciation
Right-of-use assets
Total deferred tax liabilities
Net deferred tax liability
Beginning balance
Increases to the valuation allowance
Decreases to the valuation allowance
Ending balance
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
State income taxes paid
Beginning balance
Additions for tax positions related to current year
Additions (reductions) for tax positions related to prior years
Reductions to tax positions related to lapse of statute
Ending balance
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
Operating loss carry forwards
Federal net operating loss carryforwards
State net operating loss carryforwards
Operating loss carryforwards not subject to expiration
Research and development credit carryforwards
Income taxes paid
Unrecognized tax benefits effective tax rate
Percentage of salary deposits in tax deferred investment account
Percentage of contributions made by the company
Contributions by the company
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Actual damages
Amount awarded to other party
Payment of minimum annual order amounts
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Gross profit
Segment contribution
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Revenue, Major Customer [Line Items]
Revenue
Revenue percentage
Number of reportable segments
Concentration risk percentage
Subsequent Event [Table]
Subsequent Event [Line Items]
Milestone payment
Common stock were exercised, shares
Weighted average exercise price, share
Licenses [Member]
Acquired NDAs [Member]
Acquired Product Rights [Member]
State Pharmacy Licenses [Member]
Accrued rebates and copay assistance.
Schedule Of Valuation And Qualifying Accounts Disclosure [Table Text Block]
Chargebacks [Member]
Government Rebates [Member]
Allowances For Sales Returns [Member]
Administrative Fees and Other Rebates [Member]
Co Pay Assistance [Member]
Reserves For Cash Discount [Member]
Finite lived intangible assets impairment.
Non-Competition Clause [Member]
Value for vesting of restricted stock unit and performance stock unit.
Shares for vesting of restricted stock unit and performance stock unit.
Asset Purchase Agreement [Member]
Gain loss on valuation allowances and reserves balance.
Fifth Third Revolving Credit Facility [Member]
Senior Secured Revolving Credit Facility [Member]
Unused fee rate.
Non cash lease expense.
Senior Notes Due 2030 [Member]
Acquisition of melt pharmaceuticals
Second Amendment [Member]
Oaktree Loan [Member]
Oaktree Fund Administration LLC [Member]
Oaktree Loan Due 2026 [Member]
Unaccrued exit fee.
Purchase of product NDAS and related patents.
Asset Purchase, License and Related Agreements [Member]
Upfront and milestone payments.
Payments to acquisition of melt pharmaceuticals
Notes payable percent.
8.625% Senior Notes Due 2026 [Member]
Unaccrued interest.
Merger Agreement [Member]
Samsung Agreement [Member]
Description of licenses agreements.
Formosa Agreement [Member]
11.875% Senior Notes Due 2027 [Member]
Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options.
VEVYE [Member]
Loan and Security Agreement [Member]
BR Loan [Member]
Santen Products Acquisition [Member]
Term milestone payment.
Milestone payment.
One Time Payment [Member]
Milestones receivable based on agreed revenues.
Reclassification of deferred financing costs.
Accrual of exit fee related to Oaktree Loan.
Reclassification of deferred commitment fees from prepaid expenses into debt issuance costs
Change in extension assumptions of right of use assets for operating lease obligations.
Melt Loan Agreement [Member]
Accrual of milestone payment
Series B1 Preferred Stock [Member]
Senior Notes Due Two ThousandThirty [Member]
Oaktree Loan Due January Two Thousand Twenty Six [Member]
Aggregate amount in cash.
Annual net sales milestones.
Total annual net sales milestones.
2017 Incentive Stock and Awards Plan [Member]
Consolidation basis, description.
Risks Uncertainties And Liquidity [Policy Text Block]
Stock Option Plan [Member]
Investments And Agreements Related Party Transactions [Text Block]
Surface Ophthalmics, Inc. [Member]
Noncontrolling Interest [Policy Text Block]
Employees and Consultant [Member]
Forfeiture factor rate.
Employees and Directors [Member]
Accounts receivables.
Accounts receivable, contractual adjustments.
Prepaid computer software licenses and related expenses.
Prefunded co-pay assistance.
Receivable due from related party.
Prepaid prescription drug user fees.
Investment Two [Policy Text Block]
Office and Laboratory Space [Member]
Ledgewood [Member]
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Range Seven [Member]
Range Eight [Member]
Range Nine [Member]
Range Ten [Member]
Carl sbad [Member]
New Drug Applications [Member]
Lease expiration date description.
Additional area of land.
Lease Amendment [Member]
2026 Notes [Member]
2027 Notes [Member]
Nashville [Member]
2030 Notes [Member]
Stock Options, Unvested RSUs And Unvested PSUs [Member]
Accounting Guidance Issued But Not Adopted [Policy Text Block]
Performance Stock Units PSU [Member]
Share Based Compensation Award Tranche Four [Member]
Sharebased compensation arrangement by sharebased payment award derived service period
Computer hardware gross.
Performance Stock Units [Member]
Directors [Member]
Employees [Member]
Capitalized Software Costs [Text Block]
Capitalized Software Development Costs [Table Text Block]
Capitalized Software Development Costs [Member]
Effective income tax rate reconciliation nondeductible expense stock compensation wind falls cost
Effective income tax rate reconciliation nondeductible expense transaction fees
Effective income tax rate reconciliation nondeductible expense incentive stock options
EffectiveIncomeTaxRateReconciliationChangesUnrecognizedTaxBenefits
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockCompensationWindFallsAmountCost
Asset acquisition consideration
Asset acquisition consideration othercosts
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionFeesAmount
Effective Income Tax Rate Reconciliation Nondeductible Expense Incentive Stock Options Amount
Income Tax Reconciliation Nondeductible Changes Unrecognized Tax Benefits Amount
Schedule Of Components Of Incomes Tax Expense Benefit [Table Text Block]
Effective income tax rate reconciliation excess employee remuneration.
Effective income tax rate reconciliation uncertain tax position
Effective income tax rate reconciliation provision to return true ups
Deferred Tax Asset Tax Credit carry Forwards Depreciation And Amortization.
Schedule Of Effective Incomes Tax Rate Reconciliation [Table Text Block]
OSRX Liability [Member]
Branded [Member]
ImprimisRx [Member]
Interest expense limitation carryforwards
Accrued chargebacks returns
Reportable Segment Aggregation Research and Development [Member]
Stock compensation
Accrued rebates
Lease liability
Accrued bonus
Obsolete inventory reserve
Accrued vacation
Research credit carryforwards
Other accruals and reserves
Deferred tax assets interest expense limitation carryforwards
Deferred tax asset Tax credit carry forwards depreciation and amortization
Deferred tax assets accrued chargebacks returns
Deferred tax assets stockcompensation
Deferred tax assets accrued rebates
Deferred tax assets lease liability
Schedule Of Segment Reporting Information [Text Block]
IHEEZO [Member]
Other Products [Member]
Other Revenue [Member]
Two Customer [Member]
No Customer [Member]
Single Customer [Member]
One Customer [Member]
Three Suppliers [Member]
Purchases [Member]
Santen Agreements [Member]
Deferred tax assets obsolete inventory reserve
Deferred tax assets accrued vacation
DeferredTaxAssetsResearchCreditCarryforwards
DeferredTaxAssetsOtherAccrualsAndReserves
Deferred tax liabilities tax accounting method change.
Deferred tax liabilities depreciation.
Deferred tax liabilities right of use assets.
Other offering expenses.
Deferred tax asset operating loss carry forwards.
Schedule of Valuation Allowance [Table Text Block]
Deferred tax assets increases valuation allowance.
Deferred tax assets decreases valuation allowance.
Schedule of Federal Income Tax [Table Text Block]
Percentage of salary deposits in tax deferred investment account.
Deferred tax assets accrued bonus.
Acquisition of business.
Accrual of exit fee related to loan.
Three Customers [Member]
Two Suppliers [Member]
Product Sales Net [Member]
Other Revenues [Member]
Third Party Software License [Member]
Consultants [Member]
NJ [Member]
Other [Member]
Tennessee [Member]
Colorado [Member]
Massachusetts [Member]
Tax Year 2032 [Member]
Unrecognized tax benefits increases (decreases) resulting from prior period tax positions.
Insurance premium financed.
Accounts receivable, after allowance for credit loss and contractual adjustments.
The number of equity-based payment instruments, excluding stock (or unit) options, that vested but unissued during the reporting period.
Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Cost of Product and Service Sold
Operating Expenses
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Shares, Outstanding
Stock Issued During Period, Value, Other
Stock Issued During Period, Shares, Other
Gain (Loss) on Disposition of Property Plant Equipment
Gain (Loss) on Disposition of Intangible Assets
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Employee Related Liabilities
Increase (Decrease) in Deferred Revenue
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Businesses, Gross
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Senior Debt
PaymentOfPayrollTaxesUponVestingOfPSUsRSUsAndExerciseOfStockOptions
Payments of Debt Issuance Costs
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Inventory, Policy [Policy Text Block]
Research, Development, and Computer Software, Policy [Policy Text Block]
Lessee, Leases [Policy Text Block]
Accounts Receivable, Allowance for Credit Loss, Current
Accounts Receivable, Allowance for Credit Loss, Writeoff
Balance
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Capitalized Computer Software, Accumulated Amortization
Intangible assets impairment
Indefinite-Lived Trademarks
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
IndefiniteLivedIntangibleAssetsImpairment
Finite-Lived Intangible Assets, Net
Long-Term Debt, Maturity, Year One
Long-Term Debt, Maturity, Year Two
Long-Term Debt, Maturity, Year Three
Long-Term Debt, Maturity, Year Four
Long-Term Debt, Maturity, Year Five
Long-Term Debt, Maturity, after Year Five
Long-Term Debt
Interest Expense, Operating and Nonoperating
Additional square footage
Lessee, Operating Lease, Liability, to be Paid, Year One
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid, Year Three
Lessee, Operating Lease, Liability, to be Paid, Year Four
Lessee, Operating Lease, Liability, to be Paid, Year Five
Lessee, Operating Lease, Liability, to be Paid, after Year Five
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Current Income Tax Expense (Benefit)
Deferred Federal Income Tax Expense (Benefit)
Deferred Foreign Income Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Deferred Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionFeesAmount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionFees
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
IncomeTaxReconciliationChangesUnrecognizedTaxBenefitsAmount
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent
Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net
Deferred Tax Liabilities, Gross
Deferred Tax Liabilities, Net
Unrecognized Tax Benefits
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations